Naglaa F. Khedr
El Geish Street
Tanda, GH 31527, Egypt
Tanda, GH 31527, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Formoterol induced mitochondrial biogenesis and PINK1-Parkin mitophagy via activation of β2-adrenergic receptor signaling and downregulation of miR-421/miR-103a in acute kidney injury.
Journal: Chemico-biological interactions
Published: March 16, 2026
Paraxanthine and azilsartan attenuate gentamicin-induced renal fibrosis via modulation of TGF-β1/Smad3/7 signaling and miRNA-21/miRNA-200b expression.
Journal: Journal of translational medicine
Published: November 27, 2025
Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells.
Journal: Medical oncology (Northwood, London, England)
Published: October 07, 2025
Therapeutic potential of natural compounds in the management of chronic diseases: Targeting PINK1-Parkin pathway.
Journal: Pathology, research and practice
Published: August 02, 2025
Comparative effects of empagliflozin and vildagliptin on inflammation and atrial function in patients with type 2 diabetes and coronary artery disease: EMPA-VILDA-Response trial.
Journal: European journal of pharmacology
Published: July 29, 2025
Fisetin Mitigates Ferroptosis and Promotes Remyelination in a Cuprizone Model of Multiple Sclerosis.
Fisetin Mitigates Ferroptosis and Promotes Remyelination in a Cuprizone Model of Multiple Sclerosis.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: April 13, 2025
Docosahexaenoic acid is comparable to vildagliptin in improving hyperglycemia and pancreatic insulin signaling of diabetic rats via SIRT1/Akt/PI3K pathway.
Journal: Scientific reports
Published: April 03, 2025
Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.
Journal: Frontiers in pharmacology
Published: April 01, 2025
Diagnostic and Prognostic Roles of Inflammatory Biomarkers in Patients With Coronary Heart Disease and Heart Failure Treated With Empagliflozin.
Journal: Clinical therapeutics
Published: January 23, 2025
Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 17, 2024
The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele-Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization.
Journal: Pharmacology research & perspectives
Published: November 11, 2024
Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest-posttest design study.
Journal: BMC health services research
Published: September 11, 2024
Last Updated: 09/26/2026